XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.1
SEGMENT INFORMATION (Tables)
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of segment revenues and profit
Segment revenues and profits for the three months ended March 31, 2022 and 2021 were as follows:
Three Months Ended March 31,
(in millions)20222021
Revenues:  
Vision Care$560 $556 
Ophthalmic Pharmaceuticals155 163 
Surgical174 162 
Total revenues$889 $881 
Segment profit:  
Vision Care$159 $165 
Ophthalmic Pharmaceuticals40 56 
Surgical15 16 
Total segment profit214 237 
Corporate(93)(74)
Amortization of intangible assets(65)(76)
Other expense, net(2)(2)
Operating income54 85 
Interest expense (Note 4)(20)— 
Foreign exchange and other(5)(8)
Income before provision for income taxes$29 $77 
Schedule of revenues by segment and product category
Revenues by segment and product category were as follows:
Vision CareOphthalmic PharmaceuticalsSurgicalTotal
Three Months Ended March 31,
(in millions)20222021202220212022202120222021
Pharmaceuticals$$$108 $116 $— $— $110 $121 
Devices214 223 — — 172 159 386 382 
OTC335 320 — — — — 335 320 
Branded and Other Generics46 45 — — 52 51 
Other revenues
$560 $556 $155 $163 $174 $162 $889 $881 
Schedule of revenue attributed to a geographic region
Revenues are attributed to a geographic region based on the location of the customer and were as follows:
Three Months Ended
March 31,
(in millions)20222021
U.S. and Puerto Rico$386 $377 
China82 89 
France55 52 
Japan50 58 
Germany43 41 
United Kingdom27 24 
Canada22 23 
Italy20 16 
Spain19 17 
Russia17 19 
South Korea11 13 
Poland11 10 
Mexico11 
Sweden10 
Other126 124 
$889 $881